Form 4/A for IGC IGC Pharma, Inc.
Accepted 2021-09-15 00:00:00 ET · period of report 2021-09-15 · accession 0001185185-21-001296 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AI | 2021-09-15 | 2021-05-13 | IGC | MUKUNDA RAM | CEO, Dir | A - Grant | $0.00 | +50.0K | 777.4K | +7% | $0 |
| A | 2021-09-15 | 2021-05-13 | IGC | MUKUNDA RAM | CEO, Dir | A - Grant | $0.00 | +1.00M | 3.17M | +46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2021-05-13 | A | A | 50,000 | $0.00 | 777,417 | I | — | — | (F1) Represents restricted shares of common stock subject to vesting over three years. |
| 2 | Common | COMMON STOCK | 2021-05-13 | A | A | 1,000,000 | $0.00 | 3,174,760 | D BY SPOUSE | — | — | (F1) Represents restricted shares of common stock subject to vesting over three years. (F2) This Form 4 is being filed to reflect the correct ownership amount of the Reporting Person. All previous Section 16 filings of the Reporting Person since April 19, 2013 overstated the Reporting Person's ownership by 600,000 shares. Accordingly, the Reporting person owns 3,174,760 shares of Common Stock as opposed to the 3,774,760 shares previously reported on the Form 4. |